 Angus Toland
Concepts (132)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Meningioma | 2 | 2021 | 82 | 1.320 |
Why?
| | Meningeal Neoplasms | 2 | 2021 | 93 | 1.310 |
Why?
| | Brain Neoplasms | 5 | 2024 | 1171 | 1.210 |
Why?
| | Spinal Cord Neoplasms | 3 | 2023 | 40 | 0.940 |
Why?
| | Receptor, Platelet-Derived Growth Factor alpha | 1 | 2024 | 45 | 0.900 |
Why?
| | Glioma | 2 | 2024 | 354 | 0.840 |
Why?
| | Chondrosarcoma | 1 | 2022 | 15 | 0.790 |
Why?
| | Fibroma | 1 | 2022 | 23 | 0.770 |
Why?
| | Osteosarcoma | 1 | 2022 | 72 | 0.740 |
Why?
| | Mutation | 5 | 2024 | 3717 | 0.710 |
Why?
| | Bone Neoplasms | 1 | 2022 | 231 | 0.650 |
Why?
| | Biomarkers, Tumor | 3 | 2024 | 1181 | 0.640 |
Why?
| | Astrocytoma | 2 | 2024 | 122 | 0.380 |
Why?
| | Submandibular Gland | 1 | 2025 | 19 | 0.240 |
Why?
| | Interleukin-5 | 1 | 2025 | 45 | 0.240 |
Why?
| | Churg-Strauss Syndrome | 1 | 2025 | 25 | 0.240 |
Why?
| | Perivascular Epithelioid Cell Neoplasms | 1 | 2024 | 2 | 0.240 |
Why?
| | Lymphoma, B-Cell, Marginal Zone | 1 | 2024 | 12 | 0.230 |
Why?
| | Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2024 | 56 | 0.220 |
Why?
| | Adrenoleukodystrophy | 1 | 2024 | 9 | 0.220 |
Why?
| | Proof of Concept Study | 1 | 2024 | 69 | 0.220 |
Why?
| | Anus Neoplasms | 1 | 2024 | 30 | 0.220 |
Why?
| | Fatal Outcome | 1 | 2024 | 300 | 0.220 |
Why?
| | Cauda Equina | 1 | 2023 | 6 | 0.210 |
Why?
| | Lymphoproliferative Disorders | 1 | 2023 | 54 | 0.210 |
Why?
| | Neoplasms, Germ Cell and Embryonal | 1 | 2024 | 69 | 0.200 |
Why?
| | Lymphoma, Large B-Cell, Diffuse | 1 | 2024 | 112 | 0.200 |
Why?
| | Polyomavirus | 1 | 2022 | 13 | 0.200 |
Why?
| | Atlases as Topic | 1 | 2022 | 10 | 0.200 |
Why?
| | Polyomavirus Infections | 1 | 2022 | 28 | 0.200 |
Why?
| | Nonlinear Optical Microscopy | 1 | 2022 | 1 | 0.200 |
Why?
| | Programmed Cell Death 1 Receptor | 1 | 2024 | 232 | 0.190 |
Why?
| | B7-H1 Antigen | 1 | 2024 | 196 | 0.190 |
Why?
| | Cells | 1 | 2022 | 24 | 0.190 |
Why?
| | Gangliosides | 1 | 2022 | 19 | 0.190 |
Why?
| | Epstein-Barr Virus Infections | 1 | 2023 | 94 | 0.190 |
Why?
| | Central Nervous System Neoplasms | 1 | 2024 | 149 | 0.190 |
Why?
| | Peripheral Nerves | 1 | 2022 | 69 | 0.190 |
Why?
| | Immunohistochemistry | 2 | 2024 | 1698 | 0.180 |
Why?
| | Organ Specificity | 1 | 2022 | 296 | 0.180 |
Why?
| | Neural Stem Cells | 1 | 2023 | 143 | 0.180 |
Why?
| | Ependymoma | 1 | 2023 | 177 | 0.180 |
Why?
| | Brain Stem Neoplasms | 1 | 2022 | 89 | 0.180 |
Why?
| | Ubiquitin Thiolesterase | 1 | 2021 | 42 | 0.180 |
Why?
| | Humans | 22 | 2025 | 129650 | 0.180 |
Why?
| | Sarcoma, Clear Cell | 1 | 2020 | 8 | 0.170 |
Why?
| | Chromosomal Proteins, Non-Histone | 1 | 2021 | 116 | 0.170 |
Why?
| | RNA Splicing | 1 | 2022 | 262 | 0.170 |
Why?
| | Papillomavirus Infections | 1 | 2024 | 297 | 0.170 |
Why?
| | Disease Susceptibility | 1 | 2022 | 333 | 0.170 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2025 | 759 | 0.170 |
Why?
| | Single-Cell Analysis | 1 | 2022 | 277 | 0.160 |
Why?
| | Neoplasm Grading | 1 | 2020 | 285 | 0.160 |
Why?
| | DNA Copy Number Variations | 1 | 2020 | 170 | 0.160 |
Why?
| | Transcriptome | 2 | 2022 | 887 | 0.160 |
Why?
| | Tumor Suppressor Proteins | 1 | 2021 | 317 | 0.150 |
Why?
| | Immunotherapy, Adoptive | 1 | 2022 | 295 | 0.150 |
Why?
| | Antigens, Neoplasm | 1 | 2020 | 309 | 0.140 |
Why?
| | Histones | 1 | 2022 | 588 | 0.130 |
Why?
| | Influenza, Human | 1 | 2022 | 601 | 0.130 |
Why?
| | Alzheimer Disease | 1 | 2022 | 519 | 0.130 |
Why?
| | Brain | 3 | 2023 | 2679 | 0.130 |
Why?
| | Survival Rate | 1 | 2020 | 1877 | 0.120 |
Why?
| | RNA | 1 | 2022 | 883 | 0.120 |
Why?
| | Antibodies, Monoclonal | 1 | 2022 | 1367 | 0.120 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2021 | 964 | 0.120 |
Why?
| | DNA Methylation | 1 | 2020 | 607 | 0.120 |
Why?
| | Infant, Newborn | 2 | 2024 | 5762 | 0.120 |
Why?
| | Male | 8 | 2025 | 63681 | 0.110 |
Why?
| | DNA-Binding Proteins | 1 | 2021 | 1443 | 0.110 |
Why?
| | Molecular Typing | 1 | 2013 | 20 | 0.110 |
Why?
| | Melanoma | 1 | 2020 | 730 | 0.110 |
Why?
| | Child | 6 | 2024 | 20883 | 0.100 |
Why?
| | Skin Neoplasms | 1 | 2020 | 825 | 0.100 |
Why?
| | Prognosis | 1 | 2021 | 3794 | 0.100 |
Why?
| | Escherichia coli Infections | 1 | 2013 | 112 | 0.100 |
Why?
| | Adolescent | 5 | 2025 | 20393 | 0.100 |
Why?
| | Drug Resistance, Bacterial | 1 | 2013 | 176 | 0.100 |
Why?
| | Child, Preschool | 3 | 2024 | 10517 | 0.090 |
Why?
| | Astrocytes | 2 | 2023 | 201 | 0.090 |
Why?
| | Female | 7 | 2024 | 68776 | 0.090 |
Why?
| | Lung Neoplasms | 1 | 2023 | 2344 | 0.090 |
Why?
| | Tumor Microenvironment | 2 | 2024 | 634 | 0.080 |
Why?
| | Microglia | 2 | 2022 | 235 | 0.080 |
Why?
| | Escherichia coli | 1 | 2013 | 774 | 0.080 |
Why?
| | Adult | 5 | 2024 | 35576 | 0.080 |
Why?
| | Neoplasms | 1 | 2022 | 2470 | 0.070 |
Why?
| | Mice | 4 | 2023 | 16937 | 0.060 |
Why?
| | Angiomyolipoma | 1 | 2024 | 18 | 0.060 |
Why?
| | Eye Neoplasms | 1 | 2024 | 16 | 0.060 |
Why?
| | Lymphangioleiomyomatosis | 1 | 2024 | 34 | 0.060 |
Why?
| | Infant | 3 | 2025 | 9024 | 0.050 |
Why?
| | Isocitrate Dehydrogenase | 1 | 2024 | 52 | 0.050 |
Why?
| | Anal Canal | 1 | 2024 | 88 | 0.050 |
Why?
| | Forkhead Transcription Factors | 1 | 2024 | 185 | 0.050 |
Why?
| | Microscopy | 1 | 2024 | 141 | 0.050 |
Why?
| | Endothelium | 1 | 2022 | 121 | 0.050 |
Why?
| | Neuroglia | 1 | 2023 | 168 | 0.050 |
Why?
| | Spectrum Analysis, Raman | 1 | 2022 | 41 | 0.050 |
Why?
| | Pericytes | 1 | 2022 | 28 | 0.050 |
Why?
| | California | 1 | 2022 | 401 | 0.040 |
Why?
| | Glucocorticoids | 1 | 2025 | 575 | 0.040 |
Why?
| | Young Adult | 3 | 2024 | 12426 | 0.040 |
Why?
| | Animals | 4 | 2023 | 35361 | 0.040 |
Why?
| | Middle Aged | 4 | 2024 | 31154 | 0.040 |
Why?
| | Myelin Sheath | 1 | 2022 | 160 | 0.040 |
Why?
| | Biopsy | 1 | 2024 | 1097 | 0.040 |
Why?
| | Cell Cycle Proteins | 1 | 2024 | 586 | 0.040 |
Why?
| | Homeodomain Proteins | 1 | 2024 | 495 | 0.040 |
Why?
| | Nuclear Proteins | 1 | 2024 | 663 | 0.040 |
Why?
| | Cerebral Cortex | 1 | 2022 | 437 | 0.040 |
Why?
| | Ecosystem | 1 | 2023 | 568 | 0.040 |
Why?
| | Aged, 80 and over | 2 | 2024 | 7086 | 0.040 |
Why?
| | Endothelial Cells | 1 | 2022 | 749 | 0.030 |
Why?
| | B-Lymphocytes | 1 | 2022 | 815 | 0.030 |
Why?
| | Hippocampus | 1 | 2022 | 874 | 0.030 |
Why?
| | Diagnosis, Differential | 1 | 2020 | 1434 | 0.030 |
Why?
| | Treatment Outcome | 2 | 2025 | 10230 | 0.030 |
Why?
| | Transcription Factors | 1 | 2024 | 1651 | 0.030 |
Why?
| | Sensitivity and Specificity | 1 | 2020 | 1838 | 0.030 |
Why?
| | Cell Differentiation | 1 | 2023 | 1902 | 0.030 |
Why?
| | Genome-Wide Association Study | 1 | 2022 | 1333 | 0.030 |
Why?
| | Gene Expression Profiling | 1 | 2022 | 1706 | 0.030 |
Why?
| | Neurons | 1 | 2023 | 1511 | 0.030 |
Why?
| | T-Lymphocytes | 1 | 2022 | 1928 | 0.030 |
Why?
| | Germany | 1 | 2013 | 100 | 0.030 |
Why?
| | Escherichia coli Proteins | 1 | 2013 | 178 | 0.020 |
Why?
| | Aged | 2 | 2024 | 22103 | 0.020 |
Why?
| | Sequence Analysis, DNA | 1 | 2013 | 779 | 0.020 |
Why?
| | Retrospective Studies | 1 | 2024 | 14518 | 0.020 |
Why?
| | Anti-Bacterial Agents | 1 | 2013 | 1717 | 0.010 |
Why?
| | United States | 1 | 2013 | 13903 | 0.010 |
Why?
|
|
Toland's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|